COVID-19 Impact on Global Specialty Active Pharmaceutical Ingredients Market Insights, Forecast to 2026
Specialty Active Pharmaceutical Ingredients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Active Pharmaceutical Ingredients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Specialty Active Pharmaceutical Ingredients market is segmented into
The Specialty Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Specialty Active Pharmaceutical Ingredients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Specialty Active Pharmaceutical Ingredients Market Share Analysis
Specialty Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Specialty Active Pharmaceutical Ingredients business, the date to enter into the Specialty Active Pharmaceutical Ingredients market, Specialty Active Pharmaceutical Ingredients product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Specialty Active Pharmaceutical Ingredients market is segmented into
- Steroidal API
- Peptide API
- Carbohydrate API
- Small Molecule API
- High Potency AP
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Rheumatology
- Diabetes
- Oncology
- Others
The Specialty Active Pharmaceutical Ingredients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Specialty Active Pharmaceutical Ingredients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Specialty Active Pharmaceutical Ingredients Market Share Analysis
Specialty Active Pharmaceutical Ingredients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Specialty Active Pharmaceutical Ingredients business, the date to enter into the Specialty Active Pharmaceutical Ingredients market, Specialty Active Pharmaceutical Ingredients product introduction, recent developments, etc.
The major vendors covered:
- Sanofi
- Cambrex
- Almac
- Johnson Matthey
- PolyPeptide
- AmbioPharm
- Avecia
- ST Pharm
- Biospring
1 STUDY COVERAGE
1.1 Specialty Active Pharmaceutical Ingredients Product Introduction
1.2 Market Segments
1.3 Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.4.2 Steroidal API
1.4.3 Peptide API
1.4.4 Carbohydrate API
1.4.5 Small Molecule API
1.4.6 High Potency AP
1.5 Market by Application
1.5.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Genitourinary/Hormonal Drugs
1.5.5 Rheumatology
1.5.6 Diabetes
1.5.7 Oncology
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Specialty Active Pharmaceutical Ingredients Industry Impact
1.6.1 How the Covid-19 is Affecting the Specialty Active Pharmaceutical Ingredients Industry
1.6.1.1 Specialty Active Pharmaceutical Ingredients Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Specialty Active Pharmaceutical Ingredients Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts
2.1.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026
2.1.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026
2.2 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026
2.2.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SPECIALTY ACTIVE PHARMACEUTICAL INGREDIENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020)
3.1.2 Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
3.2 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020)
3.2.2 Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Specialty Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Specialty Active Pharmaceutical Ingredients Revenue in 2019
3.2.5 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Specialty Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Specialty Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Specialty Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Type (2015-2020)
4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020)
4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2015-2020)
4.1.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Specialty Active Pharmaceutical Ingredients Market Size Forecast by Type (2021-2026)
4.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
4.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
4.2.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Application (2015-2020)
5.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020)
5.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2015-2020)
5.1.3 Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)
5.2 Specialty Active Pharmaceutical Ingredients Market Size Forecast by Application (2021-2026)
5.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
5.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
5.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Specialty Active Pharmaceutical Ingredients by Country
6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country
6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
6.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
7 EUROPE
7.1 Europe Specialty Active Pharmaceutical Ingredients by Country
7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country
7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
7.3 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Specialty Active Pharmaceutical Ingredients by Region
8.1.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region
8.1.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
8.3 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Specialty Active Pharmaceutical Ingredients by Country
9.1.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country
9.1.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
9.3 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients by Country
10.1.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country
10.1.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
10.3 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
11.1.5 Sanofi Recent Development
11.2 Cambrex
11.2.1 Cambrex Corporation Information
11.2.2 Cambrex Description, Business Overview and Total Revenue
11.2.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Products Offered
11.2.5 Cambrex Recent Development
11.3 Almac
11.3.1 Almac Corporation Information
11.3.2 Almac Description, Business Overview and Total Revenue
11.3.3 Almac Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Almac Specialty Active Pharmaceutical Ingredients Products Offered
11.3.5 Almac Recent Development
11.4 Johnson Matthey
11.4.1 Johnson Matthey Corporation Information
11.4.2 Johnson Matthey Description, Business Overview and Total Revenue
11.4.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Products Offered
11.4.5 Johnson Matthey Recent Development
11.5 PolyPeptide
11.5.1 PolyPeptide Corporation Information
11.5.2 PolyPeptide Description, Business Overview and Total Revenue
11.5.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Products Offered
11.5.5 PolyPeptide Recent Development
11.6 AmbioPharm
11.6.1 AmbioPharm Corporation Information
11.6.2 AmbioPharm Description, Business Overview and Total Revenue
11.6.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Products Offered
11.6.5 AmbioPharm Recent Development
11.7 Avecia
11.7.1 Avecia Corporation Information
11.7.2 Avecia Description, Business Overview and Total Revenue
11.7.3 Avecia Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Avecia Specialty Active Pharmaceutical Ingredients Products Offered
11.7.5 Avecia Recent Development
11.8 ST Pharm
11.8.1 ST Pharm Corporation Information
11.8.2 ST Pharm Description, Business Overview and Total Revenue
11.8.3 ST Pharm Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Products Offered
11.8.5 ST Pharm Recent Development
11.9 Biospring
11.9.1 Biospring Corporation Information
11.9.2 Biospring Description, Business Overview and Total Revenue
11.9.3 Biospring Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biospring Specialty Active Pharmaceutical Ingredients Products Offered
11.9.5 Biospring Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region
12.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Regions 2021-2026
12.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Regions 2021-2026
12.2 North America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.2.1 North America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.2.2 North America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.2.3 North America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.3 Europe Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.3.1 Europe: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.3.2 Europe: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.3.3 Europe: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Region (2021-2026)
12.5 Latin America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.5.1 Latin America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.5.2 Latin America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.5.3 Latin America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Specialty Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Specialty Active Pharmaceutical Ingredients Product Introduction
1.2 Market Segments
1.3 Key Specialty Active Pharmaceutical Ingredients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type
1.4.2 Steroidal API
1.4.3 Peptide API
1.4.4 Carbohydrate API
1.4.5 Small Molecule API
1.4.6 High Potency AP
1.5 Market by Application
1.5.1 Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Genitourinary/Hormonal Drugs
1.5.5 Rheumatology
1.5.6 Diabetes
1.5.7 Oncology
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Specialty Active Pharmaceutical Ingredients Industry Impact
1.6.1 How the Covid-19 is Affecting the Specialty Active Pharmaceutical Ingredients Industry
1.6.1.1 Specialty Active Pharmaceutical Ingredients Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Specialty Active Pharmaceutical Ingredients Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Specialty Active Pharmaceutical Ingredients Market Size Estimates and Forecasts
2.1.1 Global Specialty Active Pharmaceutical Ingredients Revenue 2015-2026
2.1.2 Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026
2.2 Specialty Active Pharmaceutical Ingredients Market Size by Region: 2020 Versus 2026
2.2.1 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Specialty Active Pharmaceutical Ingredients Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SPECIALTY ACTIVE PHARMACEUTICAL INGREDIENTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020)
3.1.2 Specialty Active Pharmaceutical Ingredients Sales Market Share by Manufacturers (2015-2020)
3.2 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020)
3.2.2 Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Specialty Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Specialty Active Pharmaceutical Ingredients Revenue in 2019
3.2.5 Global Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Specialty Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Specialty Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Specialty Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Type (2015-2020)
4.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020)
4.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2015-2020)
4.1.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Specialty Active Pharmaceutical Ingredients Market Size Forecast by Type (2021-2026)
4.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2026)
4.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Type (2021-2026)
4.2.3 Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Specialty Active Pharmaceutical Ingredients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Specialty Active Pharmaceutical Ingredients Market Size by Application (2015-2020)
5.1.1 Global Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020)
5.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue by Application (2015-2020)
5.1.3 Specialty Active Pharmaceutical Ingredients Price by Application (2015-2020)
5.2 Specialty Active Pharmaceutical Ingredients Market Size Forecast by Application (2021-2026)
5.2.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2026)
5.2.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Application (2021-2026)
5.2.3 Global Specialty Active Pharmaceutical Ingredients Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Specialty Active Pharmaceutical Ingredients by Country
6.1.1 North America Specialty Active Pharmaceutical Ingredients Sales by Country
6.1.2 North America Specialty Active Pharmaceutical Ingredients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
6.3 North America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
7 EUROPE
7.1 Europe Specialty Active Pharmaceutical Ingredients by Country
7.1.1 Europe Specialty Active Pharmaceutical Ingredients Sales by Country
7.1.2 Europe Specialty Active Pharmaceutical Ingredients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
7.3 Europe Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Specialty Active Pharmaceutical Ingredients by Region
8.1.1 Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region
8.1.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
8.3 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Specialty Active Pharmaceutical Ingredients by Country
9.1.1 Latin America Specialty Active Pharmaceutical Ingredients Sales by Country
9.1.2 Latin America Specialty Active Pharmaceutical Ingredients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
9.3 Central & South America Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients by Country
10.1.1 Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country
10.1.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Type
10.3 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
11.1.5 Sanofi Recent Development
11.2 Cambrex
11.2.1 Cambrex Corporation Information
11.2.2 Cambrex Description, Business Overview and Total Revenue
11.2.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Cambrex Specialty Active Pharmaceutical Ingredients Products Offered
11.2.5 Cambrex Recent Development
11.3 Almac
11.3.1 Almac Corporation Information
11.3.2 Almac Description, Business Overview and Total Revenue
11.3.3 Almac Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Almac Specialty Active Pharmaceutical Ingredients Products Offered
11.3.5 Almac Recent Development
11.4 Johnson Matthey
11.4.1 Johnson Matthey Corporation Information
11.4.2 Johnson Matthey Description, Business Overview and Total Revenue
11.4.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson Matthey Specialty Active Pharmaceutical Ingredients Products Offered
11.4.5 Johnson Matthey Recent Development
11.5 PolyPeptide
11.5.1 PolyPeptide Corporation Information
11.5.2 PolyPeptide Description, Business Overview and Total Revenue
11.5.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PolyPeptide Specialty Active Pharmaceutical Ingredients Products Offered
11.5.5 PolyPeptide Recent Development
11.6 AmbioPharm
11.6.1 AmbioPharm Corporation Information
11.6.2 AmbioPharm Description, Business Overview and Total Revenue
11.6.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AmbioPharm Specialty Active Pharmaceutical Ingredients Products Offered
11.6.5 AmbioPharm Recent Development
11.7 Avecia
11.7.1 Avecia Corporation Information
11.7.2 Avecia Description, Business Overview and Total Revenue
11.7.3 Avecia Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Avecia Specialty Active Pharmaceutical Ingredients Products Offered
11.7.5 Avecia Recent Development
11.8 ST Pharm
11.8.1 ST Pharm Corporation Information
11.8.2 ST Pharm Description, Business Overview and Total Revenue
11.8.3 ST Pharm Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ST Pharm Specialty Active Pharmaceutical Ingredients Products Offered
11.8.5 ST Pharm Recent Development
11.9 Biospring
11.9.1 Biospring Corporation Information
11.9.2 Biospring Description, Business Overview and Total Revenue
11.9.3 Biospring Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biospring Specialty Active Pharmaceutical Ingredients Products Offered
11.9.5 Biospring Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Specialty Active Pharmaceutical Ingredients Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Specialty Active Pharmaceutical Ingredients Market Estimates and Projections by Region
12.1.1 Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Regions 2021-2026
12.1.2 Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Regions 2021-2026
12.2 North America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.2.1 North America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.2.2 North America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.2.3 North America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.3 Europe Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.3.1 Europe: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.3.2 Europe: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.3.3 Europe: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Region (2021-2026)
12.5 Latin America Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.5.1 Latin America: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.5.2 Latin America: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.5.3 Latin America: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Specialty Active Pharmaceutical Ingredients Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Specialty Active Pharmaceutical Ingredients Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Specialty Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Specialty Active Pharmaceutical Ingredients Market Segments
Table 2. Ranking of Global Top Specialty Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Steroidal API
Table 5. Major Manufacturers of Peptide API
Table 6. Major Manufacturers of Carbohydrate API
Table 7. Major Manufacturers of Small Molecule API
Table 8. Major Manufacturers of High Potency AP
Table 9. COVID-19 Impact Global Market: (Four Specialty Active Pharmaceutical Ingredients Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Specialty Active Pharmaceutical Ingredients Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
Table 14. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Specialty Active Pharmaceutical Ingredients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Specialty Active Pharmaceutical Ingredients Sales by Regions 2015-2020 (K MT)
Table 17. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Regions (2015-2020)
Table 18. Global Specialty Active Pharmaceutical Ingredients Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)
Table 21. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)
Table 23. Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Specialty Active Pharmaceutical Ingredients Price (2015-2020) (USD/MT)
Table 26. Specialty Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
Table 28. Date of International Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 31. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 32. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Table 34. Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 36. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2015-2020)
Table 37. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 38. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 39. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 41. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 42. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 43. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 44. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 45. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 46. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 47. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 49. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 50. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 51. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 52. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 61. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 62. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 65. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 66. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 67. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 68. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 77. Sanofi Corporation Information
Table 78. Sanofi Description and Major Businesses
Table 79. Sanofi Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Sanofi Product
Table 81. Sanofi Recent Development
Table 82. Cambrex Corporation Information
Table 83. Cambrex Description and Major Businesses
Table 84. Cambrex Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Cambrex Product
Table 86. Cambrex Recent Development
Table 87. Almac Corporation Information
Table 88. Almac Description and Major Businesses
Table 89. Almac Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Almac Product
Table 91. Almac Recent Development
Table 92. Johnson Matthey Corporation Information
Table 93. Johnson Matthey Description and Major Businesses
Table 94. Johnson Matthey Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Johnson Matthey Product
Table 96. Johnson Matthey Recent Development
Table 97. PolyPeptide Corporation Information
Table 98. PolyPeptide Description and Major Businesses
Table 99. PolyPeptide Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. PolyPeptide Product
Table 101. PolyPeptide Recent Development
Table 102. AmbioPharm Corporation Information
Table 103. AmbioPharm Description and Major Businesses
Table 104. AmbioPharm Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AmbioPharm Product
Table 106. AmbioPharm Recent Development
Table 107. Avecia Corporation Information
Table 108. Avecia Description and Major Businesses
Table 109. Avecia Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Avecia Product
Table 111. Avecia Recent Development
Table 112. ST Pharm Corporation Information
Table 113. ST Pharm Description and Major Businesses
Table 114. ST Pharm Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. ST Pharm Product
Table 116. ST Pharm Recent Development
Table 117. Biospring Corporation Information
Table 118. Biospring Description and Major Businesses
Table 119. Biospring Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Biospring Product
Table 121. Biospring Recent Development
Table 122. Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Regions (2021-2026) (K MT)
Table 123. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 127. North America: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 129. Europe: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Specialty Active Pharmaceutical Ingredients Sales Forecast by Region (2021-2026) (K MT)
Table 131. Asia Pacific: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 133. Latin America: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 135. Middle East and Africa: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players
Table 140. Specialty Active Pharmaceutical Ingredients Customers List
Table 141. Specialty Active Pharmaceutical Ingredients Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
Table 1. Specialty Active Pharmaceutical Ingredients Market Segments
Table 2. Ranking of Global Top Specialty Active Pharmaceutical Ingredients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Steroidal API
Table 5. Major Manufacturers of Peptide API
Table 6. Major Manufacturers of Carbohydrate API
Table 7. Major Manufacturers of Small Molecule API
Table 8. Major Manufacturers of High Potency AP
Table 9. COVID-19 Impact Global Market: (Four Specialty Active Pharmaceutical Ingredients Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Specialty Active Pharmaceutical Ingredients Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Specialty Active Pharmaceutical Ingredients Players to Combat Covid-19 Impact
Table 14. Global Specialty Active Pharmaceutical Ingredients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global Specialty Active Pharmaceutical Ingredients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global Specialty Active Pharmaceutical Ingredients Sales by Regions 2015-2020 (K MT)
Table 17. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Regions (2015-2020)
Table 18. Global Specialty Active Pharmaceutical Ingredients Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Specialty Active Pharmaceutical Ingredients Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015-2020)
Table 21. Global Specialty Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Specialty Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Specialty Active Pharmaceutical Ingredients as of 2019)
Table 23. Specialty Active Pharmaceutical Ingredients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Specialty Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Specialty Active Pharmaceutical Ingredients Price (2015-2020) (USD/MT)
Table 26. Specialty Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Specialty Active Pharmaceutical Ingredients Product Type
Table 28. Date of International Manufacturers Enter into Specialty Active Pharmaceutical Ingredients Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 31. Global Specialty Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 32. Global Specialty Active Pharmaceutical Ingredients Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Specialty Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Table 34. Specialty Active Pharmaceutical Ingredients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 36. Global Specialty Active Pharmaceutical Ingredients Sales Share by Application (2015-2020)
Table 37. North America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 38. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 39. North America Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 41. North America Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 42. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 43. North America Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 44. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 45. Europe Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 46. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 47. Europe Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 49. Europe Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 50. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 51. Europe Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 52. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 61. Latin America Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 62. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 65. Latin America Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 66. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 67. Latin America Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 68. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Table 77. Sanofi Corporation Information
Table 78. Sanofi Description and Major Businesses
Table 79. Sanofi Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Sanofi Product
Table 81. Sanofi Recent Development
Table 82. Cambrex Corporation Information
Table 83. Cambrex Description and Major Businesses
Table 84. Cambrex Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Cambrex Product
Table 86. Cambrex Recent Development
Table 87. Almac Corporation Information
Table 88. Almac Description and Major Businesses
Table 89. Almac Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Almac Product
Table 91. Almac Recent Development
Table 92. Johnson Matthey Corporation Information
Table 93. Johnson Matthey Description and Major Businesses
Table 94. Johnson Matthey Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Johnson Matthey Product
Table 96. Johnson Matthey Recent Development
Table 97. PolyPeptide Corporation Information
Table 98. PolyPeptide Description and Major Businesses
Table 99. PolyPeptide Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. PolyPeptide Product
Table 101. PolyPeptide Recent Development
Table 102. AmbioPharm Corporation Information
Table 103. AmbioPharm Description and Major Businesses
Table 104. AmbioPharm Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AmbioPharm Product
Table 106. AmbioPharm Recent Development
Table 107. Avecia Corporation Information
Table 108. Avecia Description and Major Businesses
Table 109. Avecia Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Avecia Product
Table 111. Avecia Recent Development
Table 112. ST Pharm Corporation Information
Table 113. ST Pharm Description and Major Businesses
Table 114. ST Pharm Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. ST Pharm Product
Table 116. ST Pharm Recent Development
Table 117. Biospring Corporation Information
Table 118. Biospring Description and Major Businesses
Table 119. Biospring Specialty Active Pharmaceutical Ingredients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Biospring Product
Table 121. Biospring Recent Development
Table 122. Global Specialty Active Pharmaceutical Ingredients Sales Forecast by Regions (2021-2026) (K MT)
Table 123. Global Specialty Active Pharmaceutical Ingredients Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Specialty Active Pharmaceutical Ingredients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 127. North America: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 129. Europe: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Specialty Active Pharmaceutical Ingredients Sales Forecast by Region (2021-2026) (K MT)
Table 131. Asia Pacific: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 133. Latin America: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Specialty Active Pharmaceutical Ingredients Sales Forecast by Country (2021-2026) (K MT)
Table 135. Middle East and Africa: Specialty Active Pharmaceutical Ingredients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Specialty Active Pharmaceutical Ingredients Players
Table 140. Specialty Active Pharmaceutical Ingredients Customers List
Table 141. Specialty Active Pharmaceutical Ingredients Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Specialty Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2026
Figure 3. Steroidal API Product Picture
Figure 4. Peptide API Product Picture
Figure 5. Carbohydrate API Product Picture
Figure 6. Small Molecule API Product Picture
Figure 7. High Potency AP Product Picture
Figure 8. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2026
Figure 9. CNS
Figure 10. Cardiovascular
Figure 11. Genitourinary/Hormonal Drugs
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Specialty Active Pharmaceutical Ingredients Report Years Considered
Figure 17. Global Specialty Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)
Figure 18. Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026 (K MT)
Figure 19. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Figure 21. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 22. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Figure 23. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2019
Figure 26. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Figure 28. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 29. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)
Figure 30. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type in 2019
Figure 31. Global Specialty Active Pharmaceutical Ingredients Market Share by Price Range (2015-2020)
Figure 32. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Figure 33. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 34. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
Figure 35. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application in 2019
Figure 36. North America Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 39. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 40. U.S. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 45. North America Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 46. Europe Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 49. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 50. Germany Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 61. Europe Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 62. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 65. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 66. China Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 89. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 90. Latin America Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 93. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 94. Mexico Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 101. Latin America Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 102. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 106. Turkey Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 113. Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Almac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Avecia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Biospring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. North America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Europe Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Latin America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 132. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
Figure 1. Specialty Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2020 & 2026
Figure 3. Steroidal API Product Picture
Figure 4. Peptide API Product Picture
Figure 5. Carbohydrate API Product Picture
Figure 6. Small Molecule API Product Picture
Figure 7. High Potency AP Product Picture
Figure 8. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2020 & 2026
Figure 9. CNS
Figure 10. Cardiovascular
Figure 11. Genitourinary/Hormonal Drugs
Figure 12. Rheumatology
Figure 13. Diabetes
Figure 14. Oncology
Figure 15. Others
Figure 16. Specialty Active Pharmaceutical Ingredients Report Years Considered
Figure 17. Global Specialty Active Pharmaceutical Ingredients Market Size 2015-2026 (US$ Million)
Figure 18. Global Specialty Active Pharmaceutical Ingredients Sales 2015-2026 (K MT)
Figure 19. Global Specialty Active Pharmaceutical Ingredients Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region (2015-2020)
Figure 21. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 22. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region (2015-2020)
Figure 23. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 24. Global Specialty Active Pharmaceutical Ingredients Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Specialty Active Pharmaceutical Ingredients Revenue in 2019
Figure 26. Specialty Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type (2015-2020)
Figure 28. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Type in 2019
Figure 29. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type (2015-2020)
Figure 30. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Type in 2019
Figure 31. Global Specialty Active Pharmaceutical Ingredients Market Share by Price Range (2015-2020)
Figure 32. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
Figure 33. Global Specialty Active Pharmaceutical Ingredients Sales Market Share by Application in 2019
Figure 34. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
Figure 35. Global Specialty Active Pharmaceutical Ingredients Revenue Market Share by Application in 2019
Figure 36. North America Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 39. North America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 40. U.S. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 45. North America Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 46. Europe Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 49. Europe Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 50. Germany Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 61. Europe Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 62. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Market Share by Region in 2019
Figure 65. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Market Share by Region in 2019
Figure 66. China Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 89. Asia Pacific Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 90. Latin America Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 93. Latin America Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 94. Mexico Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 101. Latin America Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 102. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Market Share by Country in 2019
Figure 106. Turkey Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Specialty Active Pharmaceutical Ingredients Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Specialty Active Pharmaceutical Ingredients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Share by Type in 2019
Figure 113. Middle East and Africa Specialty Active Pharmaceutical Ingredients Market Share by Application in 2019
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Cambrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Almac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Johnson Matthey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Avecia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. ST Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Biospring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. North America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Europe Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Asia Pacific Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Latin America Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Specialty Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 132. Middle East and Africa Specialty Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
